Table 4 PONV risk in relation to the level of prophylaxis
Number of patients (%) with PONV | All patients (n = 99) | Suboptimal PONV prophylaxis (n = 27) | Optimal PONV prophylaxis (n = 72) | p-value |
|---|---|---|---|---|
0 h–6 h | 26 (26%) | 9 (33%) | 17 (24%) | p = 0.44 |
6 h–Day 1 | 26 (26%) | 12 (44%) | 14 (19%) | p < 0.05 |
Day 1–Day 2 | 20 (20%) | 12 (44%) | 8 (11%) | p < 0.01 |
Day 2–Day 3 | 20 (20%) | 8 (30%) | 12 (17%) | p = 0.17 |
0 h–Day 1 | 36 (36%) | 15 (56%) | 21 (29%) | p < 0.05 |
0 h–Day 3 | 46 (46%) | 19 (70%) | 27 (38%) | p < 0.01 |